# Contineum Therapeutics, Inc.: filings

CTNM · Nasdaq · CIK 1855175 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctnm.md) · [Financials](/companies/ctnm/financials.md) · [Filings](/companies/ctnm/filings.md) · [Insiders](/companies/ctnm/insiders.md)

## Reports and events: 41 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 63, 8-K 26, 144 20, 3 14, 10-Q 8, SCHEDULE 13G/A 8, SCHEDULE 13G 6, CORRESP 5, S-8 4, UPLOAD 4, 424B5 3, SC 13G 3, 10-K 2, ARS 2, DEF 14A 2, DEFA14A 2, DRS/A 2, DRSLTR 2, EFFECT 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, S-1 1, S-1/A 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 20:07 ET | [8-K](/filings/0001628280-26-061834.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-061834 |
| 2026-07-30 | 20:11 ET | [10-Q](/filings/0001628280-26-051054.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051054 |
| 2026-07-30 | 20:08 ET | [8-K](/filings/0001628280-26-051051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051051 |
| 2026-07-13 | 20:15 ET | [8-K](/filings/0001628280-26-048023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048023 |
| 2026-06-26 | 20:48 ET | [8-K](/filings/0001628280-26-045804.md) | 5.07 Shareholder vote results | 0001628280-26-045804 |
| 2026-05-05 | 20:24 ET | [10-Q](/filings/0001628280-26-030614.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030614 |
| 2026-05-05 | 20:09 ET | [8-K](/filings/0001628280-26-030522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030522 |
| 2026-04-30 | 20:08 ET | [DEF 14A](/filings/0001628280-26-028881.md) | Proxy statement, period 2026-06-26 | 0001628280-26-028881 |
| 2026-04-30 | 20:07 ET | [8-K](/filings/0001628280-26-028876.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-028876 |
| 2026-03-05 | 21:09 ET | [10-K](/filings/0001628280-26-015165.md) | Annual report, period 2025-12-31 | 0001628280-26-015165 |
| 2026-03-05 | 21:06 ET | [8-K](/filings/0001628280-26-015159.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-015159 |
| 2026-01-26 | 21:06 ET | [8-K](/filings/0001437749-26-002072.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-002072 |
| 2025-12-15 | 21:05 ET | [8-K](/filings/0001437749-25-037842.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037842 |
| 2025-12-11 | 21:01 ET | [8-K](/filings/0001437749-25-037547.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037547 |
| 2025-11-20 | 21:07 ET | [8-K](/filings/0001437749-25-035860.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-035860 |
| 2025-10-30 | 20:13 ET | [10-Q](/filings/0001437749-25-032427.md) | Quarterly report, period 2025-09-30 | 0001437749-25-032427 |
| 2025-10-30 | 20:09 ET | [8-K](/filings/0001437749-25-032422.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-032422 |
| 2025-09-18 | 12:16 ET | [8-K](/filings/0001437749-25-029349.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-029349 |
| 2025-08-05 | 20:13 ET | [10-Q](/filings/0001437749-25-024852.md) | Quarterly report, period 2025-06-30 | 0001437749-25-024852 |
| 2025-08-05 | 20:08 ET | [8-K](/filings/0001437749-25-024849.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-024849 |
| 2025-06-26 | 20:07 ET | [8-K](/filings/0001437749-25-021343.md) | 5.07 Shareholder vote results | 0001437749-25-021343 |
| 2025-05-14 | 20:44 ET | [8-K](/filings/0001437749-25-016877.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016877 |
| 2025-05-14 | 20:08 ET | [10-Q](/filings/0001437749-25-016835.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016835 |
| 2025-04-29 | 20:07 ET | [DEF 14A](/filings/0001437749-25-013528.md) | Proxy statement, period 2025-06-26 | 0001437749-25-013528 |
| 2025-04-28 | 20:10 ET | [8-K](/filings/0001437749-25-013334.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013334 |
| 2025-03-17 | 20:07 ET | [8-K](/filings/0001437749-25-007998.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-007998 |
| 2025-03-06 | 21:10 ET | [10-K](/filings/0001437749-25-006458.md) | Annual report, period 2024-12-31 | 0001437749-25-006458 |
| 2025-03-06 | 21:08 ET | [8-K](/filings/0001437749-25-006457.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-006457 |
| 2024-11-06 | 21:10 ET | [10-Q](/filings/0001437749-24-033616.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033616 |
| 2024-11-06 | 21:08 ET | [8-K](/filings/0001437749-24-033614.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-033614 |
| 2024-08-14 | 16:46 ET | [10-Q](/filings/0001437749-24-026680.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026680 |
| 2024-08-14 | 16:19 ET | [8-K/A](/filings/0001437749-24-026664.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026664 |
| 2024-08-13 | 20:10 ET | [8-K](/filings/0001437749-24-026385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-026385 |
| 2024-06-24 | 20:11 ET | [8-K](/filings/0001437749-24-021083.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-021083 |
| 2024-05-31 | 21:10 ET | [8-K](/filings/0001437749-24-018934.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-018934 |
| 2024-05-20 | 20:09 ET | [8-K](/filings/0001437749-24-017651.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-017651 |
| 2024-05-16 | 21:01 ET | [10-Q](/filings/0001437749-24-017320.md) | Quarterly report, period 2024-03-31 | 0001437749-24-017320 |
| 2024-05-16 | 20:08 ET | [8-K](/filings/0001437749-24-017293.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-017293 |
| 2024-04-09 | 20:49 ET | [8-K](/filings/0001193125-24-090917.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-090917 |
| 2024-04-01 | 12:41 ET | [S-1/A](/filings/0001193125-24-082755.md) | Registration statement, amended | 0001193125-24-082755 |
| 2024-03-15 | 21:04 ET | [S-1](/filings/0001193125-24-069256.md) | Registration statement | 0001193125-24-069256 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.